- Home
- ITP vs ZVSA Comparison
ITP vs ZVSA Comparison
Compare ITP & ZVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITP
- ZVSA
- Stock Information
- Founded
- ITP 1996
- ZVSA 2014
- Country
- ITP China
- ZVSA United States
- Employees
- ITP N/A
- ZVSA N/A
- Industry
- ITP Paper
- ZVSA Biotechnology: Pharmaceutical Preparations
- Sector
- ITP Basic Materials
- ZVSA Health Care
- Exchange
- ITP Nasdaq
- ZVSA Nasdaq
- Market Cap
- ITP 2.6M
- ZVSA 2.5M
- IPO Year
- ITP N/A
- ZVSA N/A
- Fundamental
- Price
- ITP $0.20
- ZVSA $0.65
- Analyst Decision
- ITP
- ZVSA
- Analyst Count
- ITP 0
- ZVSA 0
- Target Price
- ITP N/A
- ZVSA N/A
- AVG Volume (30 Days)
- ITP 17.4M
- ZVSA 968.0K
- Earning Date
- ITP 05-09-2025
- ZVSA 06-17-2025
- Dividend Yield
- ITP N/A
- ZVSA N/A
- EPS Growth
- ITP N/A
- ZVSA N/A
- EPS
- ITP N/A
- ZVSA N/A
- Revenue
- ITP $79,871,368.00
- ZVSA N/A
- Revenue This Year
- ITP N/A
- ZVSA N/A
- Revenue Next Year
- ITP N/A
- ZVSA N/A
- P/E Ratio
- ITP N/A
- ZVSA N/A
- Revenue Growth
- ITP 8.49
- ZVSA N/A
- 52 Week Low
- ITP $0.15
- ZVSA $0.47
- 52 Week High
- ITP $1.07
- ZVSA $6.30
- Technical
- Relative Strength Index (RSI)
- ITP 46.95
- ZVSA 54.57
- Support Level
- ITP $0.16
- ZVSA $0.60
- Resistance Level
- ITP $0.22
- ZVSA $0.73
- Average True Range (ATR)
- ITP 0.02
- ZVSA 0.07
- MACD
- ITP 0.00
- ZVSA 0.02
- Stochastic Oscillator
- ITP 66.83
- ZVSA 64.83
About ITP IT Tech Packaging Inc.
IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.